Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
QLYS Quote, Financials, Valuation and Earnings
Last price:
$139.46
Seasonality move
:
6.28%
Day range:
$137.04 - $139.08
52-week range:
$112.61 - $170.00
Dividend yield:
0%
P/E ratio:
28.32x
P/S ratio:
8.27x
P/B ratio:
10.10x
Volume:
240K
Avg. volume:
310.2K
1-year change:
-6.76%
Market cap:
$5B
Revenue:
$607.6M
EPS (TTM):
$4.89
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $363M | $411.2M | $489.7M | $554.5M | $607.6M | |
| Revenue Growth (YoY) | 12.86% | 13.28% | 19.1% | 13.22% | 9.58% | |
| Cost of Revenues | $79.2M | $89.4M | $102.8M | $107.5M | $111.5M | |
| Gross Profit | $283.7M | $321.7M | $386.9M | $447M | $496.1M | |
| Gross Profit Margin | 78.17% | 78.25% | 79.01% | 80.61% | 81.65% | |
| R&D Expenses | $72.5M | $81.3M | $101.2M | $110.5M | $111.9M | |
| Selling, General & Admin | $114.5M | $152.8M | $155.2M | $173.4M | $197M | |
| Other Inc / (Exp) | $7K | -$573K | -$2M | -$1.3M | -$3.2M | |
| Operating Expenses | $187.1M | $234.1M | $256.4M | $283.9M | $308.9M | |
| Operating Income | $96.7M | $87.7M | $130.5M | $163.1M | $187.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $102M | $89.4M | $133.7M | $178.7M | $209.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $10.5M | $18.4M | $25.7M | $27.1M | $36.1M | |
| Net Income to Company | $91.6M | $71M | $108M | $151.6M | $173.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $91.6M | $71M | $108M | $151.6M | $173.7M | |
| Basic EPS (Cont. Ops) | $2.34 | $1.82 | $2.81 | $4.11 | $4.72 | |
| Diluted EPS (Cont. Ops) | $2.25 | $1.77 | $2.74 | $4.03 | $4.65 | |
| Weighted Average Basic Share | $39.2M | $39M | $38.5M | $36.9M | $36.8M | |
| Weighted Average Diluted Share | $40.7M | $40.1M | $39.3M | $37.6M | $37.4M | |
| EBITDA | $134.9M | $123.6M | $165.2M | $190.1M | $205.7M | |
| EBIT | $102M | $87.7M | $130.5M | $163.1M | $187.2M | |
| Revenue (Reported) | $363M | $411.2M | $489.7M | $554.5M | $607.6M | |
| Operating Income (Reported) | $96.7M | $87.7M | $130.5M | $163.1M | $187.2M | |
| Operating Income (Adjusted) | $102M | $87.7M | $130.5M | $163.1M | $187.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $96.8M | $113.4M | $130.7M | $145.8M | $159.9M | |
| Revenue Growth (YoY) | 12.16% | 17.22% | 15.22% | 11.57% | 9.67% | |
| Cost of Revenues | $21.7M | $24M | $27M | $27.2M | $28.9M | |
| Gross Profit | $75.1M | $89.4M | $103.7M | $118.6M | $131M | |
| Gross Profit Margin | 77.59% | 78.84% | 79.38% | 81.35% | 81.91% | |
| R&D Expenses | $17.7M | $23.1M | $27.8M | $27.5M | $29.2M | |
| Selling, General & Admin | $60M | $32.8M | $40.8M | $46.3M | $50.1M | |
| Other Inc / (Exp) | -$244K | -$710K | -$216K | -$1.4M | $317K | |
| Operating Expenses | $77.8M | $55.9M | $68.6M | $73.8M | $79.2M | |
| Operating Income | -$2.7M | $33.5M | $35.2M | $44.8M | $51.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$2.2M | $33.3M | $37.4M | $49.5M | $58.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.4M | $7.9M | $8.3M | $9.8M | $10.8M | |
| Net Income to Company | $228K | $25.4M | $29.1M | $39.7M | $47.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $228K | $25.4M | $29.1M | $39.7M | $47.5M | |
| Basic EPS (Cont. Ops) | $0.01 | $0.65 | $0.79 | $1.08 | $1.30 | |
| Diluted EPS (Cont. Ops) | $0.01 | $0.64 | $0.77 | $1.05 | $1.29 | |
| Weighted Average Basic Share | $39.2M | $39M | $37.1M | $37M | $36.5M | |
| Weighted Average Diluted Share | $40.4M | $40M | $37.7M | $37.7M | $36.8M | |
| EBITDA | $6.9M | $42.5M | $42.6M | $50M | $55.9M | |
| EBIT | -$2.2M | $33.5M | $35.2M | $44.8M | $51.8M | |
| Revenue (Reported) | $96.8M | $113.4M | $130.7M | $145.8M | $159.9M | |
| Operating Income (Reported) | -$2.7M | $33.5M | $35.2M | $44.8M | $51.8M | |
| Operating Income (Adjusted) | -$2.2M | $33.5M | $35.2M | $44.8M | $51.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $373.5M | $427.8M | $507M | $569.6M | $621.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $82.4M | $91.8M | $105.7M | $107.7M | $113.2M | |
| Gross Profit | $291M | $336.1M | $401.2M | $461.9M | $508.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $72.3M | $86.6M | $105.9M | $110.2M | $113.5M | |
| Selling, General & Admin | $145.2M | $125.5M | $163.2M | $179M | $200.8M | |
| Other Inc / (Exp) | -$102K | -$1M | -$1.5M | -$2.5M | -$1.4M | |
| Operating Expenses | $217.5M | $212.2M | $269.1M | $289.2M | $314.3M | |
| Operating Income | $73.5M | $123.9M | $132.2M | $172.7M | $194.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $77.6M | $124.9M | $137.7M | $190.8M | $218.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.5M | $28.8M | $26M | $28.6M | $37.2M | |
| Net Income to Company | $73.1M | $96.1M | $111.7M | $162.2M | $181.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $73.1M | $96.1M | $111.7M | $162.2M | $181.5M | |
| Basic EPS (Cont. Ops) | $1.87 | $2.46 | $2.95 | $4.41 | $4.95 | |
| Diluted EPS (Cont. Ops) | $1.80 | $2.42 | $2.89 | $4.32 | $4.89 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $111.8M | $159.2M | $165.3M | $197.4M | $211.6M | |
| EBIT | $77.6M | $123.4M | $132.2M | $172.7M | $194.2M | |
| Revenue (Reported) | $373.5M | $427.8M | $507M | $569.6M | $621.7M | |
| Operating Income (Reported) | $73.5M | $123.9M | $132.2M | $172.7M | $194.2M | |
| Operating Income (Adjusted) | $77.6M | $123.4M | $132.2M | $172.7M | $194.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $96.8M | $113.4M | $130.7M | $145.8M | $159.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $21.7M | $24M | $27M | $27.2M | $28.9M | |
| Gross Profit | $75.1M | $89.4M | $103.7M | $118.6M | $131M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $17.7M | $23.1M | $27.8M | $27.5M | $29.2M | |
| Selling, General & Admin | $60M | $32.8M | $40.8M | $46.3M | $50.1M | |
| Other Inc / (Exp) | -$244K | -$710K | -$216K | -$1.4M | $317K | |
| Operating Expenses | $77.8M | $55.9M | $68.6M | $73.8M | $79.2M | |
| Operating Income | -$2.7M | $33.5M | $35.2M | $44.8M | $51.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$2.2M | $33.3M | $37.4M | $49.5M | $58.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.4M | $7.9M | $8.3M | $9.8M | $10.8M | |
| Net Income to Company | $228K | $25.4M | $29.1M | $39.7M | $47.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $228K | $25.4M | $29.1M | $39.7M | $47.5M | |
| Basic EPS (Cont. Ops) | $0.01 | $0.65 | $0.79 | $1.08 | $1.30 | |
| Diluted EPS (Cont. Ops) | $0.01 | $0.64 | $0.77 | $1.05 | $1.29 | |
| Weighted Average Basic Share | $39.2M | $39M | $37.1M | $37M | $36.5M | |
| Weighted Average Diluted Share | $40.4M | $40M | $37.7M | $37.7M | $36.8M | |
| EBITDA | $6.9M | $42.5M | $42.6M | $50M | $55.9M | |
| EBIT | -$2.2M | $33.5M | $35.2M | $44.8M | $51.8M | |
| Revenue (Reported) | $96.8M | $113.4M | $130.7M | $145.8M | $159.9M | |
| Operating Income (Reported) | -$2.7M | $33.5M | $35.2M | $44.8M | $51.8M | |
| Operating Income (Adjusted) | -$2.2M | $33.5M | $35.2M | $44.8M | $51.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $74.1M | $137.3M | $173.7M | $203.7M | $232.2M | |
| Short Term Investments | $281.9M | $268M | $147.6M | $221.9M | $149.2M | |
| Accounts Receivable, Net | $100.2M | $109M | $121.8M | $146.2M | $164.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $19.1M | -- | -- | -- | -- | |
| Other Current Assets | -- | $32.1M | $30.2M | $26.7M | $39.7M | |
| Total Current Assets | $475.3M | $546.4M | $473.3M | $600M | $585.7M | |
| Property Plant And Equipment | $109.7M | $98.9M | $81.2M | $55M | $71.3M | |
| Long-Term Investments | $98.5M | $111.2M | $59.2M | $56.6M | $193.9M | |
| Goodwill | $7.4M | $7.4M | $7.4M | $7.4M | $7.4M | |
| Other Intangibles | $12M | $6.5M | $12.8M | $9.7M | $6.8M | |
| Other Long-Term Assets | $18.1M | $19M | $21.6M | $21.1M | $27.1M | |
| Total Assets | $736.8M | $814.6M | $700.9M | $812.6M | $973.5M | |
| Accounts Payable | $731K | $1.3M | $2.8M | $988K | $1.3M | |
| Accrued Expenses | $29.8M | $32.5M | $42.6M | $43.1M | $45.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $11.7M | $12.6M | $13.1M | $11.9M | $9.7M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $255.7M | $304.3M | $352.2M | $389.2M | $428.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $332.3M | $377.8M | $411.8M | $444.4M | $496.4M | |
| Common Stock | $39K | $39K | $37K | $37K | $37K | |
| Other Common Equity Adj | -$484K | $1M | -$1.9M | -$1.7M | $1.4M | |
| Common Equity | $404.5M | $436.7M | $289.1M | $368.2M | $477.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $404.5M | $436.7M | $289.1M | $368.2M | $477.1M | |
| Total Liabilities and Equity | $736.8M | $814.6M | $700.9M | $812.6M | $973.5M | |
| Cash and Short Terms | $356M | $405.3M | $321.3M | $425.6M | $381.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $108.8M | $166.3M | $193.9M | $273.8M | $290.7M | |
| Short Term Investments | $248M | $290.9M | $139.9M | $179.9M | $150.2M | |
| Accounts Receivable, Net | $85.2M | $89.3M | $101.8M | $115.6M | $121.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $22.1M | $26.8M | -- | -- | -- | |
| Other Current Assets | -- | -- | $29.2M | $36.1M | $39.5M | |
| Total Current Assets | $464.1M | $573.2M | $464.7M | $605.4M | $601.9M | |
| Property Plant And Equipment | $106.3M | $97.9M | $75.9M | $61.6M | $69.6M | |
| Long-Term Investments | $101.5M | $82.4M | $44.6M | $89.7M | $199M | |
| Goodwill | $7.4M | $7.4M | $7.4M | $7.4M | $7.4M | |
| Other Intangibles | $10.4M | $4.8M | $12M | $8.9M | $6.2M | |
| Other Long-Term Assets | $19.6M | $18.8M | $21.2M | $22.2M | $26.3M | |
| Total Assets | $729.9M | $814.6M | $675.8M | $861.8M | $996.5M | |
| Accounts Payable | $1.2M | $2.5M | $1.7M | $645K | $1.3M | |
| Accrued Expenses | $27.8M | $37.1M | $41.8M | $48.2M | $52.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $11.8M | $12M | $12.9M | $10M | $11M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $259.7M | $318.5M | $353M | $391.1M | $432M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $332.8M | $387.9M | $407.9M | $457.6M | $498.4M | |
| Common Stock | $39K | $39K | $37K | $37K | $36K | |
| Other Common Equity Adj | $120K | -$670K | -$1.6M | -$1M | $136K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $397.1M | $426.6M | $267.8M | $404.2M | $498M | |
| Total Liabilities and Equity | $729.9M | $814.6M | $675.8M | $861.8M | $996.5M | |
| Cash and Short Terms | $356.7M | $457.1M | $333.8M | $453.7M | $440.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $91.6M | $71M | $108M | $151.6M | $173.7M | |
| Depreciation & Amoritzation | $32.8M | $35.9M | $34.6M | $27M | $18.5M | |
| Stock-Based Compensation | $40M | $67.6M | $53.4M | $69.1M | $77.1M | |
| Change in Accounts Receivable | -$22.6M | -$9.2M | -$13.4M | -$25M | -$19.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $180.1M | $200.6M | $198.9M | $244.6M | $244.1M | |
| Capital Expenditures | $31.5M | $25.7M | $24M | $8.8M | $12.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$80.9M | -$29.5M | $145.1M | -$73.2M | -$71.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$114K | -$90K | -- | -- | -- | |
| Repurchase of Common Stock | -$126.7M | -$130M | -$317.3M | -$170.8M | -$139.9M | |
| Other Financing Activities | -$20.2M | -$27.8M | -$17.6M | -$22.3M | -$29.9M | |
| Cash From Financing | -$112.6M | -$107.9M | -$306M | -$141.5M | -$145.7M | |
| Beginning Cash (CF) | $88.8M | $75.3M | $138.5M | $176.4M | $206.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$13.4M | $63.2M | $37.9M | $29.9M | $27M | |
| Ending Cash (CF) | $75.3M | $138.5M | $176.4M | $206.4M | $233.4M | |
| Levered Free Cash Flow | $148.5M | $175M | $174.9M | $235.8M | $231.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $228K | $25.4M | $29.1M | $39.7M | $47.5M | |
| Depreciation & Amoritzation | $9.1M | $9M | $7.4M | $5.2M | $4.2M | |
| Stock-Based Compensation | $38.2M | $11.7M | $16M | $19M | $18.8M | |
| Change in Accounts Receivable | $14.8M | $19.6M | $19.9M | $30.4M | $42.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $57.9M | $79M | $66.8M | $85.5M | $109.6M | |
| Capital Expenditures | $6.3M | $7.6M | $4M | $2.1M | $2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $23.2M | -$4.5M | $19.7M | $8.1M | -$7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$31M | -$46.6M | -$66.6M | -$18M | -$39.7M | |
| Other Financing Activities | -$17.6M | -$3.6M | -$5.1M | -$13.3M | -$10.8M | |
| Cash From Financing | -$46.4M | -$45.6M | -$66.3M | -$25M | -$44.1M | |
| Beginning Cash (CF) | $75.3M | $138.5M | $176.4M | $206.4M | $233.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $34.6M | $29M | $20.1M | $68.6M | $58.5M | |
| Ending Cash (CF) | $110M | $167.5M | $196.6M | $275M | $291.9M | |
| Levered Free Cash Flow | $51.6M | $71.4M | $62.8M | $83.5M | $107.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $73.1M | $96.1M | $111.7M | $162.2M | $181.5M | |
| Depreciation & Amoritzation | $34.2M | $35.8M | $33.1M | $24.8M | $17.5M | |
| Stock-Based Compensation | $68.2M | $41.1M | $57.7M | $72.1M | $76.9M | |
| Change in Accounts Receivable | -$13M | -$4.5M | -$13.1M | -$14.5M | -$6.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $185.5M | $221.8M | $186.6M | $263.3M | $268.2M | |
| Capital Expenditures | $30.5M | $27M | $20.4M | $6.8M | $12.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$94.6M | -$57.2M | $169.3M | -$84.8M | -$86.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$128.8M | -$145.5M | -$337.3M | -$122.3M | -$161.5M | |
| Other Financing Activities | -$32.8M | -$13.8M | -$19.1M | -$30.5M | -$27.4M | |
| Cash From Financing | -$129.7M | -$107M | -$326.8M | -$100.1M | -$164.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$38.8M | $57.5M | $29.1M | $78.4M | $16.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $155M | $194.8M | $166.2M | $256.5M | $255.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $228K | $25.4M | $29.1M | $39.7M | $47.5M | |
| Depreciation & Amoritzation | $9.1M | $9M | $7.4M | $5.2M | $4.2M | |
| Stock-Based Compensation | $38.2M | $11.7M | $16M | $19M | $18.8M | |
| Change in Accounts Receivable | $14.8M | $19.6M | $19.9M | $30.4M | $42.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $57.9M | $79M | $66.8M | $85.5M | $109.6M | |
| Capital Expenditures | $6.3M | $7.6M | $4M | $2.1M | $2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $23.2M | -$4.5M | $19.7M | $8.1M | -$7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$31M | -$46.6M | -$66.6M | -$18M | -$39.7M | |
| Other Financing Activities | -$17.6M | -$3.6M | -$5.1M | -$13.3M | -$10.8M | |
| Cash From Financing | -$46.4M | -$45.6M | -$66.3M | -$25M | -$44.1M | |
| Beginning Cash (CF) | $75.3M | $138.5M | $176.4M | $206.4M | $233.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $34.6M | $29M | $20.1M | $68.6M | $58.5M | |
| Ending Cash (CF) | $110M | $167.5M | $196.6M | $275M | $291.9M | |
| Levered Free Cash Flow | $51.6M | $71.4M | $62.8M | $83.5M | $107.6M | |
Get QLYS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
QLYS
Sector
P/E ratio
28.32x
23.84x
PEG ratio
2.15x
0.00x
P/B ratio
10.10x
2.31x
Price / LTM sales
8.27x
1.64x
Growth Metrics
QLYS
Sector
Revenue growth
9.67%
3.84%
Earnings growth
22.86%
10.8%
Revenue (5-year growth)
13.57%
6.27%
Earnings forecast
$1.48
$0.12
Profitability
QLYS
Sector
Profitability FY 2024
$496.1M
$77.3M
Return on invested capital
40.21%
0.05%
Return on assets
19.66%
-0.48%
Return on equity
40.21%
0.73%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
5
Balance Sheet
QLYS
Sector
Total cash
$440.9M
$48.7M
Short term investments
$149.2M
$19.4M
Total assets
$973.5M
$223.8M
Long term debt
--
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
